Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Traumatic Brain Injury
100%
Growth Hormone Deficiency
100%
Recombinant Human Growth Hormone Therapy
100%
Scoping Review
100%
Recombinant Human Growth Hormone (r-hGH)
66%
Growth Hormone
50%
Randomized Placebo-controlled Trial
50%
Brain Injury
33%
Abnormal Growth
33%
Growth Hormone Secretion
33%
Peak Growth
33%
Growth Factors
16%
Quality of Life
16%
Physical Function
16%
Clinical Practice Guidelines
16%
Insulin-like
16%
Healthy Controls
16%
MEDLINE
16%
Retrospective Cohort Study
16%
Exclusion Criteria
16%
Physical Performance
16%
Functional Magnetic Resonance Imaging
16%
Post-traumatic Hypopituitarism
16%
Traumatic Brain Injury Patients
16%
Neuropsychological Performance
16%
Biochemical Markers
16%
Cortical Thickness
16%
Search Strategy
16%
Physical Cognition
16%
Gray Matter Volume
16%
Clinical Observational Study
16%
Symptomatic Improvement
16%
Response to Growth Hormone
16%
Functional Connectivity
16%
Neuroimaging Data
16%
Non-randomized Controlled Trial
16%
Structural Neuroimaging
16%
Comprehensive Search
16%
Somatosensory Network
16%
Hormone Use
16%
Marker Data
16%
Single-arm Trial
16%
Growth Hormone Stimulation Test
16%
Growth Hormone Response
16%
Diagnostic Cutoffs
16%
Neuroscience
Neurotrauma
100%
Traumatic Brain Injury
100%
Growth Hormone Deficiency
100%
Hormone Therapy
100%
Recombinant Growth Hormone
100%
Bovine Somatotropin
62%
Human Growth Hormone
62%
Growth Hormone
62%
Placebo
37%
Brain Injury
25%
Insulin-Like Growth Factor 1
12%
Hypopituitarism
12%
Randomized Controlled Trial
12%
Clinical Guideline
12%
Crossover Study
12%
Functional Connectivity
12%
Functional Neuroimaging
12%
Gray Matter Volume
12%
Quality of Life
12%
Cortical Thickness
12%